Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Budesonide Aerosol Market Report 2017

  • QYR2225789
  • 111 Pages
  • November 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Budesonide Aerosol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Budesonide Aerosol in these regions, from 2012 to 2022 (forecast).

United States Budesonide Aerosol market competition by top manufacturers/players, with Budesonide Aerosol sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

AstraZeneca

Pfizer

Teva

Cipla

Novartis

Mylan

Abbott

Takeda

Boehringer Ingelheim

Allgen Pharmaceuticals

Squibb

Sandoz

Shimadzu Corp

Manus Aktteva Biopharma LLP

Skyepharma

Shanghai Sine Pharmaceutical

Lunan Better Pharmaceutical

Wellcome Australia Ltd

Synmosa Biopharma Corporation

Chiesi Farmaceutici S.p.A

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

50ug/200 Spray

100ug/200 Spray

200ug/100 Spray

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals

Clinics

Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Budesonide Aerosol Market Report 2017

1 Budesonide Aerosol Overview

1.1 Product Overview and Scope of Budesonide Aerosol

1.2 Classification of Budesonide Aerosol by Product Category

1.2.1 United States Budesonide Aerosol Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Budesonide Aerosol Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 50ug/200 Spray

1.2.4 100ug/200 Spray

1.2.5 200ug/100 Spray

1.2.6 Other

1.3 United States Budesonide Aerosol Market by Application/End Users

1.3.1 United States Budesonide Aerosol Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 United States Budesonide Aerosol Market by Region

1.4.1 United States Budesonide Aerosol Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Budesonide Aerosol Status and Prospect (2012-2022)

1.4.3 Southwest Budesonide Aerosol Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Budesonide Aerosol Status and Prospect (2012-2022)

1.4.5 New England Budesonide Aerosol Status and Prospect (2012-2022)

1.4.6 The South Budesonide Aerosol Status and Prospect (2012-2022)

1.4.7 The Midwest Budesonide Aerosol Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Budesonide Aerosol (2012-2022)

1.5.1 United States Budesonide Aerosol Sales and Growth Rate (2012-2022)

1.5.2 United States Budesonide Aerosol Revenue and Growth Rate (2012-2022)

2 United States Budesonide Aerosol Market Competition by Players/Suppliers

2.1 United States Budesonide Aerosol Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Budesonide Aerosol Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Budesonide Aerosol Average Price by Players/Suppliers (2012-2017)

2.4 United States Budesonide Aerosol Market Competitive Situation and Trends

2.4.1 United States Budesonide Aerosol Market Concentration Rate

2.4.2 United States Budesonide Aerosol Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Budesonide Aerosol Manufacturing Base Distribution, Sales Area, Product Type

3 United States Budesonide Aerosol Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Budesonide Aerosol Sales and Market Share by Region (2012-2017)

3.2 United States Budesonide Aerosol Revenue and Market Share by Region (2012-2017)

3.3 United States Budesonide Aerosol Price by Region (2012-2017)

4 United States Budesonide Aerosol Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Budesonide Aerosol Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Budesonide Aerosol Revenue and Market Share by Type (2012-2017)

4.3 United States Budesonide Aerosol Price by Type (2012-2017)

4.4 United States Budesonide Aerosol Sales Growth Rate by Type (2012-2017)

5 United States Budesonide Aerosol Sales (Volume) by Application (2012-2017)

5.1 United States Budesonide Aerosol Sales and Market Share by Application (2012-2017)

5.2 United States Budesonide Aerosol Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Budesonide Aerosol Players/Suppliers Profiles and Sales Data

6.1 AstraZeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Budesonide Aerosol Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AstraZeneca Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Pfizer

6.2.2 Budesonide Aerosol Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Pfizer Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Teva

6.3.2 Budesonide Aerosol Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Teva Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Cipla

6.4.2 Budesonide Aerosol Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Cipla Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novartis

6.5.2 Budesonide Aerosol Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novartis Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Mylan

6.6.2 Budesonide Aerosol Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Mylan Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Abbott

6.7.2 Budesonide Aerosol Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Abbott Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Takeda

6.8.2 Budesonide Aerosol Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Takeda Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Boehringer Ingelheim

6.9.2 Budesonide Aerosol Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Boehringer Ingelheim Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Allgen Pharmaceuticals

6.10.2 Budesonide Aerosol Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Allgen Pharmaceuticals Budesonide Aerosol Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Squibb

6.12 Sandoz

6.13 Shimadzu Corp

6.14 Manus Aktteva Biopharma LLP

6.15 Skyepharma

6.16 Shanghai Sine Pharmaceutical

6.17 Lunan Better Pharmaceutical

6.18 Wellcome Australia Ltd

6.19 Synmosa Biopharma Corporation

6.20 Chiesi Farmaceutici S.p.A

7 Budesonide Aerosol Manufacturing Cost Analysis

7.1 Budesonide Aerosol Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Budesonide Aerosol

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Budesonide Aerosol Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Budesonide Aerosol Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Budesonide Aerosol Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Budesonide Aerosol Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Budesonide Aerosol Sales Volume Forecast by Type (2017-2022)

11.3 United States Budesonide Aerosol Sales Volume Forecast by Application (2017-2022)

11.4 United States Budesonide Aerosol Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Budesonide Aerosol

Figure United States Budesonide Aerosol Market Size (K Pcs) by Type (2012-2022)

Figure United States Budesonide Aerosol Sales Volume Market Share by Type (Product Category) in 2016

Figure 50ug/200 Spray Product Picture

Figure 100ug/200 Spray Product Picture

Figure 200ug/100 Spray Product Picture

Figure Other Product Picture

Figure United States Budesonide Aerosol Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Budesonide Aerosol by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Budesonide Aerosol Market Size (Million USD) by Region (2012-2022)

Figure The West Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Budesonide Aerosol Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Budesonide Aerosol Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Budesonide Aerosol Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Budesonide Aerosol Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Budesonide Aerosol Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Budesonide Aerosol Sales Share by Players/Suppliers

Figure 2017 United States Budesonide Aerosol Sales Share by Players/Suppliers

Figure United States Budesonide Aerosol Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Budesonide Aerosol Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Budesonide Aerosol Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Budesonide Aerosol Revenue Share by Players/Suppliers

Figure 2017 United States Budesonide Aerosol Revenue Share by Players/Suppliers

Table United States Market Budesonide Aerosol Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Budesonide Aerosol Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Budesonide Aerosol Market Share of Top 3 Players/Suppliers

Figure United States Budesonide Aerosol Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Budesonide Aerosol Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Budesonide Aerosol Product Category

Table United States Budesonide Aerosol Sales (K Pcs) by Region (2012-2017)

Table United States Budesonide Aerosol Sales Share by Region (2012-2017)

Figure United States Budesonide Aerosol Sales Share by Region (2012-2017)

Figure United States Budesonide Aerosol Sales Market Share by Region in 2016

Table United States Budesonide Aerosol Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Budesonide Aerosol Revenue Share by Region (2012-2017)

Figure United States Budesonide Aerosol Revenue Market Share by Region (2012-2017)

Figure United States Budesonide Aerosol Revenue Market Share by Region in 2016

Table United States Budesonide Aerosol Price (USD/Pcs) by Region (2012-2017)

Table United States Budesonide Aerosol Sales (K Pcs) by Type (2012-2017)

Table United States Budesonide Aerosol Sales Share by Type (2012-2017)

Figure United States Budesonide Aerosol Sales Share by Type (2012-2017)

Figure United States Budesonide Aerosol Sales Market Share by Type in 2016

Table United States Budesonide Aerosol Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Budesonide Aerosol Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Budesonide Aerosol by Type (2012-2017)

Figure Revenue Market Share of Budesonide Aerosol by Type in 2016

Table United States Budesonide Aerosol Price (USD/Pcs) by Types (2012-2017)

Figure United States Budesonide Aerosol Sales Growth Rate by Type (2012-2017)

Table United States Budesonide Aerosol Sales (K Pcs) by Application (2012-2017)

Table United States Budesonide Aerosol Sales Market Share by Application (2012-2017)

Figure United States Budesonide Aerosol Sales Market Share by Application (2012-2017)

Figure United States Budesonide Aerosol Sales Market Share by Application in 2016

Table United States Budesonide Aerosol Sales Growth Rate by Application (2012-2017)

Figure United States Budesonide Aerosol Sales Growth Rate by Application (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure AstraZeneca Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure AstraZeneca Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure AstraZeneca Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Pfizer Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Pfizer Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Teva Basic Information List

Table Teva Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Teva Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Teva Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Teva Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Cipla Basic Information List

Table Cipla Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Cipla Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Cipla Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Cipla Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Novartis Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novartis Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Novartis Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Novartis Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mylan Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Mylan Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Mylan Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Abbott Basic Information List

Table Abbott Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Abbott Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Abbott Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Abbott Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Takeda Basic Information List

Table Takeda Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Takeda Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Takeda Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Takeda Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Boehringer Ingelheim Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Boehringer Ingelheim Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Boehringer Ingelheim Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Allgen Pharmaceuticals Basic Information List

Table Allgen Pharmaceuticals Budesonide Aerosol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Allgen Pharmaceuticals Budesonide Aerosol Sales Growth Rate (2012-2017)

Figure Allgen Pharmaceuticals Budesonide Aerosol Sales Market Share in United States (2012-2017)

Figure Allgen Pharmaceuticals Budesonide Aerosol Revenue Market Share in United States (2012-2017)

Table Squibb Basic Information List

Table Sandoz Basic Information List

Table Shimadzu Corp Basic Information List

Table Manus Aktteva Biopharma LLP Basic Information List

Table Skyepharma Basic Information List

Table Shanghai Sine Pharmaceutical Basic Information List

Table Lunan Better Pharmaceutical Basic Information List

Table Wellcome Australia Ltd Basic Information List

Table Synmosa Biopharma Corporation Basic Information List

Table Chiesi Farmaceutici S.p.A Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Budesonide Aerosol

Figure Manufacturing Process Analysis of Budesonide Aerosol

Figure Budesonide Aerosol Industrial Chain Analysis

Table Raw Materials Sources of Budesonide Aerosol Major Players/Suppliers in 2016

Table Major Buyers of Budesonide Aerosol

Table Distributors/Traders List

Figure United States Budesonide Aerosol Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Budesonide Aerosol Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Budesonide Aerosol Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Budesonide Aerosol Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Budesonide Aerosol Sales Volume Share Forecast by Region (2017-2022)

Figure United States Budesonide Aerosol Sales Volume Share Forecast by Region (2017-2022)

Figure United States Budesonide Aerosol Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370